Table 2.
Site of Thromboembolic Event | |||||||||
---|---|---|---|---|---|---|---|---|---|
DVT * 12/58 (20.6%) |
PE ** “De Novo” 21/58 (36.2%) |
DVT + PE 3/58 (5.1%) |
Stroke 11/58 (18.9%) |
Acute Myocardial Infarction 5/58 (8.6%) |
Arterial Thrombosis, Excluding MI and Stroke 4/58 (6.8%) |
DVT + PE + Arterial Thrombosis + Acute Myocardial Infarction 1/58 (1.7%) |
PE + Cerebral Thrombosis 1/58 (1.7%) |
||
SEX | n° (%) | ||||||||
Male | 36 (62) | 7 | 18 | 3 | 2 | 4 | 1 | 1 | 0 |
Female | 22 (37.9) | 5 | 3 | 0 | 9 | 1 | 3 | 0 | 1 |
COMORBIDITIES | n° | ||||||||
Hypertension | 4 | 1 | 2 | - | 1 | - | - | - | - |
Obesity | 6 | 1 | 5 | - | - | - | - | - | - |
Diabetes | 3 | 1 | 1 | - | - | 1 | - | - | - |
Pregnancy | 3 | 1 | - | - | 1 | 1 | - | - | - |
Neoplasia | 3 | 2 | 1 | - | - | - | - | - | - |
Coagulation disorders | 3 | 1 | - | - | - | - | 2 | - | - |
Smokers | 4 | - | 2 | - | - | 2 | - | - | - |
Obesity + hypertension | 3 | - | 3 | - | - | - | - | - | - |
Hypertension + smoking habit | 3 | - | 2 | - | - | - | - | 1 | - |
Hypertension + obesity + smoking habit | 1 | - | 1 | - | - | - | - | - | - |
Autoimmune diseases | 1 | - | 1 | - | - | - | - | - | - |
Immunosuppression | 5 | 4 | 1 | - | - | - | - | - | - |
Ischemic heart disease | 3 | - | 1 | - | - | 1 | - | 1 | - |
Dyslipidemia | 3 | 1 | 2 | - | - | - | - | - | - |
Chronic kidney disease | 1 | - | 1 | - | - | - | - | - | - |
Asthma/COPD *** | 3 | 1 | 2 | - | - | - | - | - | - |
No comorbidities/not reported | 25 | 4 | 5 | 3 | 8 | 2 | 2 | - | 1 |
Drug users | 2 | - | - | - | 1 | 1 | - | - | - |
Outcome (dead) | 3 (25%) |
7 (33.3%) |
1 (33.3%) |
1 (9%) |
3 (60%) |
1 (20%) |
0 | 0 |
* DVT—deep venous thrombosis ** PE—pulmonary embolism. *** Chronic obstructive pulmonary disease.